
Loading, please wait...

Loading, please wait...

Customizing pediatric assistive technology involves a highly complex and individualized process designed to support functional independence. However, research indicates that if devices do not fit properly, children often abandon them shortly after delivery. A recent study examined 27 children and young adults to understand these usage patterns and abandonment rates. Consequently, findings revealed a significant 37% abandonment rate among users of customized assistive technology (AT). This highlights a critical gap in the current service delivery model for younger populations.
The study showed that most products aimed to improve activities of daily living, sleep, and mobility. For instance, parents and therapists noted that satisfaction with the product directly correlated with sustained use. Furthermore, users who perceived an improvement in their quality of life were far less likely to stop using the devices. Therefore, clinicians must focus on identifying unmet needs accurately during the initial development phase.
Systematic follow-up after device implementation acts as a vital safety net for families. Additionally, providing ongoing training helps children adapt to the technology as their physical needs change over time. Because many abandonment cases occur within the first year, early intervention by therapists is essential. In conclusion, careful tailoring and regular assessments significantly enhance the therapeutic value of assistive devices.
Early abandonment usually results from an improper fit or the device failing to meet the child’s specific daily needs. Satisfaction with the product and perceived improvements in quality of life are the strongest predictors of continued use.
Providers can improve retention by accurately identifying unmet needs and ensuring the device is carefully tailored to the individual. Implementing a systematic follow-up schedule after delivery allows for necessary adjustments and ongoing training.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Swisa Y et al. Investigating user satisfaction, usage characteristics, and early abandonment of customized assistive devices for children and young adults. Disabil Rehabil Assist Technol. 2026 Mar 22. doi: 10.1080/17483107.2026.2647946. PMID: 41865382.
World Health Organization. Global report on assistive technology. Geneva: World Health Organization; 2022.
Badhal S, et al. Challenges and Barriers in Assistive Technology and the Scale for Their Assessment: A Global and Indian Perspective. ResearchGate. 2026 Mar 11.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Customized assistive devices for children have a 37% abandonment rate, highlighting the need for better tailoring and follow-up to improve quality of life....
7 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today